153 related articles for article (PubMed ID: 18830263)
21. CXCR7 expression in diffuse large B-cell lymphoma identifies a subgroup of CXCR4+ patients with good prognosis.
Moreno MJ; Gallardo A; Novelli S; Mozos A; Aragó M; Pavón MÁ; Céspedes MV; Pallarès V; Falgàs A; Alcoceba M; Blanco O; Gonzalez-Díaz M; Sierra J; Mangues R; Casanova I
PLoS One; 2018; 13(6):e0198789. PubMed ID: 29920526
[TBL] [Abstract][Full Text] [Related]
22. Follicular lymphoma with trisomy 18 exhibiting loss of BCL-2 expression on transformation to a large cell lymphoma.
Masir N; Ventura R; Jones M; Marafioti T; Mason DY; Samol J
J Clin Pathol; 2007 Sep; 60(9):1061-4. PubMed ID: 17182663
[No Abstract] [Full Text] [Related]
23. Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma.
Xie X; Sundram U; Natkunam Y; Kohler S; Hoppe RT; Kim YH; Cook JR; Hammel J; Swerdlow SH; Guitart J; Smith MD; Bosler D; Listinsky C; Lossos IS; Hsi ED
Mod Pathol; 2008 Jun; 21(6):653-9. PubMed ID: 18264083
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.
Giachelia M; Voso MT; Tisi MC; Martini M; Bozzoli V; Massini G; D'Aló F; Larocca LM; Leone G; Hohaus S
Leuk Lymphoma; 2012 Mar; 53(3):411-6. PubMed ID: 21902578
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of the CDKN2A tumor-suppressor gene by deletion or methylation is common at diagnosis in follicular lymphoma and associated with poor clinical outcome.
Alhejaily A; Day AG; Feilotter HE; Baetz T; Lebrun DP
Clin Cancer Res; 2014 Mar; 20(6):1676-86. PubMed ID: 24449825
[TBL] [Abstract][Full Text] [Related]
26. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
[TBL] [Abstract][Full Text] [Related]
27. Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma.
Kim JE; Singh RR; Cho-Vega JH; Drakos E; Davuluri Y; Khokhar FA; Fayad L; Medeiros LJ; Vega F
Mod Pathol; 2009 Oct; 22(10):1312-20. PubMed ID: 19593328
[TBL] [Abstract][Full Text] [Related]
28. CD5 expression correlates with inferior survival and enhances the negative effect of p53 overexpression in diffuse large B-cell lymphoma.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Meng B; Zhang H
Hematol Oncol; 2019 Oct; 37(4):360-367. PubMed ID: 31359442
[TBL] [Abstract][Full Text] [Related]
29. Follicular origin of a subset of CD5(+) diffuse large B-cell lymphomas.
Catherwood MA; Venkatraman L
Am J Clin Pathol; 2006 Jun; 125(6):954-5. PubMed ID: 16761357
[No Abstract] [Full Text] [Related]
30. Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients.
Thunberg U; Enblad G; Turesson I; Berglund M
Leuk Lymphoma; 2010 Aug; 51(8):1563-6. PubMed ID: 20578820
[No Abstract] [Full Text] [Related]
31. [Pathogenesis of follicular lymphoma].
Zhang PH; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):56-8. PubMed ID: 17374241
[No Abstract] [Full Text] [Related]
32. The prognostic value of 25-hydroxy vitamin D deficiency and its interaction with c-Myc expression in diffuse large B cell lymphoma.
Wang WT; Liang JH; Wang L; Zhu HY; Xia Y; Fan L; Li JY; Xu W
Ann Hematol; 2020 Oct; 99(10):2377-2384. PubMed ID: 32728938
[TBL] [Abstract][Full Text] [Related]
33. The 3q27 and 18q21 translocations for follicular lymphoma and diffuse large B-cell lymphoma in the rituximab era.
Watanabe R; Tomita N; Matsumoto C; Hattori Y; Matsuura S; Takasaki H; Hashimoto C; Fujita H; Fujisawa S; Ishigatsubo Y
J Clin Exp Hematop; 2013; 53(2):107-14. PubMed ID: 23995106
[TBL] [Abstract][Full Text] [Related]
34. N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.
Cocco P; Zucca M; Sanna S; Satta G; Nonne T; Angelucci E; Gabbas A; Rais M; Malpeli G; Campagna M; Scarpa A; G Ennas M
Hematol Oncol; 2016 Jun; 34(2):79-83. PubMed ID: 25689677
[TBL] [Abstract][Full Text] [Related]
35. VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma.
Kim MK; Suh C; Chi HS; Cho HS; Bae YK; Lee KH; Lee GW; Kim IS; Eom HS; Kong SY; Bae SH; Ryoo HM; Shin IH; Mun YC; Chung H; Hyun MS
Cancer Sci; 2012 Mar; 103(3):497-503. PubMed ID: 22129133
[TBL] [Abstract][Full Text] [Related]
36. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
37. Re: the feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma.
Stelow EB; Hong SM; Covell JL; Moskaluk CA
Cancer; 2007 Jun; 111(3):200-1; author reply 201-2. PubMed ID: 17520702
[No Abstract] [Full Text] [Related]
38. Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas.
Aggarwal N; Swerdlow SH; Kelly LM; Ogilvie JB; Nikiforova MN; Sathanoori M; Nikiforov YE
Mod Pathol; 2012 Sep; 25(9):1203-11. PubMed ID: 22575864
[TBL] [Abstract][Full Text] [Related]
39. Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.
Hu LY; Xu XL; Rao HL; Chen J; Lai RC; Huang HQ; Jiang WQ; Lin TY; Xia ZJ; Cai QQ
Chin J Cancer; 2017 Dec; 36(1):94. PubMed ID: 29246182
[TBL] [Abstract][Full Text] [Related]
40. BCL-6 protein is expressed in germinal-center B cells.
Cattoretti G; Chang CC; Cechova K; Zhang J; Ye BH; Falini B; Louie DC; Offit K; Chaganti RS; Dalla-Favera R
Blood; 1995 Jul; 86(1):45-53. PubMed ID: 7795255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
